Trial intelligence / Profile preview

Vitamin D therapy to reduce cardiovascular risk in Type 2 diabetes – the next steps

2007-003767-51Phase 4Completed

Sponsor: University of Dundee
Start: Nov 2007
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries: 1

Overview

Phase 4, randomised trial of vitamin d in type 2 diabetes mellitus (T2DM) and cardiac morbidity (2 arms), sponsored by University of Dundee. Primary endpoint: Change in endothelial function. Started Nov 2007; status: completed.

Drugs

vitamin d

Conditions

type 2 diabetes mellitus (T2DM)cardiac morbidity

Beyond the preview

Go deeper on 2007-003767-51.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003767-51.